作者：
Richard A,Hartz [1]
;
Vijay T,Ahuja [1]
;
Susheel J,Nara [2]
;
C M Vijaya,Kumar [2]
;
Raju K V L P,Manepalli [2]
;
Sarat Kumar,Sarvasiddhi [2]
;
Swarnamba,Honkhambe [2]
;
Vidya,Patankar [2]
;
Bireshwar,Dasgupta [1]
;
Ramkumar,Rajamani [3]
;
Jodi K,Muckelbauer [4]
;
Daniel M,Camac [4]
;
Kaushik,Ghosh [2]
;
Matthew,Pokross [4]
;
Susan E,Kiefer [5]
;
Jeffrey M,Brown [6]
;
Lisa,Hunihan [6]
;
Michael,Gulianello [6]
;
Martin,Lewis [6]
;
Jonathan S,Lippy [7]
;
Neha,Surti [7]
;
Brian D,Hamman [8]
;
Jason,Allen [8]
;
Walter A,Kostich [6]
;
Joanne J,Bronson [1]
;
John E,Macor [1]
;
Carolyn D,Dzierba [1]
作者单位：
Department of Small Molecule Drug Discovery, Bristol Myers Squibb Company, Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States.
[1]
Biocon-Bristol Myers Squibb Research and Development Center, Biocon Park, Plot No. 2 & 3, Bommasandra Phase IV, Jigani Link Road, Bangalore 560099, India.
[2]
Department of Molecular Structure and Design, Bristol Myers Squibb Company, Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States.
[3]
Department of Molecular Structure and Design, Bristol Myers Squibb Company, Research and Development, P.O. Box 5400, Princeton, New Jersey 08543, United States.
[4]
Department of Protein Science, Bristol Myers Squibb Company, Research and Development, P.O. Box 5400, Princeton, New Jersey 08543, United States.
[5]
Department of Neuroscience Discovery Biology, Bristol Myers Squibb Company, Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States.
[6]
Department of Lead Evaluation, Bristol Myers Squibb Company, Research and Development, P.O. Box 5400, Princeton, New Jersey 08543, United States.
[7]
Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, Texas 77381, United States.
[8]
DOI
10.1021/acs.jmedchem.1c01966
PMID
35171586
发布时间
2022-05-06
换一批
换一批
